Sustainability

Home SustainabilityESG Data

ESG Data

Hisamitsu Pharmaceutical Group’s CO₂ emissions（Scope 1 & 2）

Unit FY2021 FY2022 FY2023
Hisamitsu Pharmaceutical Group*1 t 33,220 34,452 34,439
 Group emission intensity
 (CO₂ emissions/Consolidated net sales）		 t/million yen 0.28 0.27 0.24
 Hisamitsu Pharmaceutical Co., Inc.
 [Non-consolidated]		 t 22,785 22,140 22,468
 Emission intensity of Hisamitsu
 Pharmaceutical, nonconsolidated
 (CO₂ emissions/nonconsolidated net		 t/million yen 0.25 0.24 0.23
  Kyushu Head Office t 12,428 11,736 12,756
  Utsunomiya Factory t 6,240 6,242 6,132
  Tsukuba Laboratories t 2,183 2,132 1,790
  Tokyo Head Office /
  Branches and Sales Offices		 t 1,934 2,030 1,790
 Japan subsidiaries*2 t 1,748 1,576 1,962
 Overseas subsidiaries*3 t 8,687 10,736 10,009

*1 The data above excludes domestic and overseas subsidiaries and overseas sales offices that have a negligible impact on the calculation of CO₂ emissions.
*2 Four companies with manufacturing plants: Noven, Hisamitsu Indonesia, Hisamitsu Vietnam, and Hisamitsu Brazil
*3 Three companies: CRCC Media Co., Ltd., Saga City-Vision Co., Ltd., and SAGA Hisamitsu Springs Co., Ltd.

CO₂ emissions in the supply chain
(Hisamitsu Pharmaceutical Co., Inc.
[Non-consolidated]; Scope 1, 2, and 3)

Unit FY2021 FY2022 FY2023
Scope 1（Direct emissions） t 6,923 7,862 7,186
Scope 2（Indirect emissions） t 15,862 14,278 15,282
Scope 3 t 93,816 98,488 111,566
 Category 1: Purchased goods and
 services		 t 48,284 49,823 46,290
 Category 2: Capital goods t 9,605 11,651 31,891
 Category 3: Fuel- and energy-related
 activities not included in Scope 1 or 2		 t 4,723 4,885 4,763
 Category 4: Transportation, delivery
 (upstream)		 t 2,039 2,234 2,197
 Category 5: Waste from business t 2,317 2,433 2,196
 Category 6: Business travel t 281 340 610
 Category 7: Employee commuting t 315 271 286
 Category 8: Leased assets (upstream) t ー ー ー
 Category 9: Transportation and delivery
 (downstream)		 t 30 33 35
 Category 10: Processing of sold products t ー ー ー
 Category 11: Use of sold products t ー ー ー
 Category 12: End-of-life treatment of
 sold products		 t 26,222 26,818 23,298
 Category 13: Leased assets
 (downstream)		 t ー ー ー
 Category 14: Franchises t ー ー ー
 Category 15: Investments t ー ー ー
Total t 116,601 120,628 134,034

*The values listed in the Database of emission intensity for Calculating Each Organization’s Greenhouse Gas Emissions throughout Its Supply Chain (Ver 3.2), Ministry of the Environment

Energy consumption
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Hisamitsu Pharmaceutical Co., Inc.
[Non-consolidated]		 kL 12,153 11,844 11,517
(Non-consolidated)
Energy consumption per unit
(energy consumption / non-consolidated sales [million yen])		 kL/million yen 0.13 0.13 0.12
 Kyushu Head Office
 (Crude oil equivalent)		 kL 7,049 6,687 6,473
  Electricity Mwh 21,143 20,871 20,367
  Gas (LNG) ㎥ 2,082 291,363 690,506
  Heavy oil kL 1,721 1,093 562
 Utsunomiya Factory
 (Crude oil equivalent)		 kL 3,186 3,168 3,102
  Electricity Mwh 10,474 10,679 10,366
  Steam t 16,173 15,627 16,209
 Tsukuba Laboratories
 (Crude oil equivalent)		 kL 1,090 1,051 1,045
  Electricity Mwh 3,275 3,188 3,198
  Kerosene kL 289 272 262
 Tokyo Head Office / Branches and Sales
 Offices (Crude oil equivalent)		 kL 828 938 897
  Electricity Mwh 927 480 414
  Gas (LNG) ㎥ 809 1,298 1,301
  Gasoline kL 656 674 640

Energy consumption by type
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Energy type Unit FY2021 FY2022 FY2023
Purchased electricity MWh 35,820 35,656 35,345
Steam supplied from an external heat source GJ 40,755 38,188 42,555
City gas ㎥ 809 363,094 698,625
LPG kg 4,546 5,835 6,657
Heavy oil A kL 1,732 1,044 589
Gasoline kL 656 657 640
Light oil kL 2 1 1
Kerosene kL 289 272 240

Energy consumption at overseas factories

Overseas subsidiaries Energy Unit FY2021 FY2022 FY2023
Noven Electricity MWh 10,709 10,302 10,387
Gas
（LNG）		 ㎥ 110,805 114,403 143,684
Light oil kL 0.0 0.0 0
Hisamitsu Vietnam Electricity MWh 2,386 3,773 3,573
Gas
（LPG）		 ㎥ 30,893 48,797 30,648
Light oil kL 2.1 2.7 1.7
Hisamitsu Indonesia Electricity MWh 2,357 3,274 3,439
Light oil kL 112 256 312
Hisamitsu Brazil Electricity MWh 2,544 2,489 3,501
Gas
（LPG）		 ㎥ 6,186 4,156 6,822
Light oil kL 50 36 58

Water withdrawal by water source and drainage volume by destination (Hisamitsu Pharmaceutical Group)

Unit FY2021 FY2022 FY2023
Water
withdrawal
by water
source		 Total water withdrawal ㎥ 256,073 272,886 280,951
 Municipal potable water ㎥ 175,699 186,549 187,843
 Industrial water ㎥ 49,930 49,332 55,920
 Surface water from rivers, lakes,
 natural ponds, etc.		 ㎥ 0 0 0
 Groundwater from wells and
 boreholes		 ㎥ 30,444 37,005 37,188
 Used quarry water collected
 in the quarry		 ㎥ 0 0 0
 External wastewater ㎥ 0 0 0
 Harvested rainwater ㎥ 0 0 0
 Sea water, water extracted from
 the sea or the ocean		 ㎥ 0 0 0
Drainage
volume by
destination		 Total Drainage volume*1 ㎥ 92,801 86,520 131,351
 Sewage ㎥ 92,801 86,520 88,625
 Rivers*2 ㎥ 0 0 42,726
 Ocean ㎥ 0 0 0
 Surface water ㎥ 0 0 0
Amount recycled ㎥ 26,200 39,079 39,495

*1 Total of the drainage volumes monitored.
*2 Hisamitsu Pharmaceutical Co., Inc. (non-consolidated) discharges water that meets the discharge standards into rivers, but does not monitor the volume.

Water withdrawal and drainage volumes at overseas factories

Unit FY2021 FY2022 FY2023
Total of overseas subsidiaries Water withdrawal ㎥ 80,245 98,877 107,850
Drainage volume ㎥ ー ー 44,344
Noven Water withdrawal ㎥ 17,293 22,240 20,365
Drainage volume ㎥ ー ー ー
Hisamitsu Vietnam Water withdrawal ㎥ 33,255 50,519 54,627
Drainage volume ㎥ ー ー 38,239
Hisamitsu Indonesia Water withdrawal ㎥ 10,789 17,051 32,378
Drainage volume ㎥ ー ー 5,913
Hisamitsu Brazil Water withdrawal ㎥ 18,087 9,067 480
Drainage volume ㎥ ー ー 192

*Sampled water: Tap water for Noven, Hisamitsu Vietnam and Hisamitsu Indonesia; well water for Hisamitsu Brazil

Water withdrawals in water-stressed areas

Water stress level Base Unit FY2021 FY2022 FY2023
Low（＜10%） Hisamitsu Brazil ㎥ 18,087 9,067 480
Low - medium（10 - 20%） Tosu Factory, SAGA Global Research Center, Noven, Hisamitsu Vietnam, Hisamitsu Indonesia ㎥ 167,964 196,221 207,356
Medium - high（20 - 40%） Utsunomiya Factory ㎥ 59,437 58,256 64,040
High（40 - 80%） N/A ㎥ ー ー ー
Extremely high（＞80％） N/A ㎥ ー ー ー

Water intake, drainage volume, and water pollutant emissions
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Water withdrawal ㎥ 176,649 174,009 173,101
Water consumption intensity
(Water consumption/nonconsolidated net sales)		 ㎥/million yen 1.95 1.87 1.79
Drainage volume ㎥ 92,801 86,520 87,007
BOD*1 emissions t 8.5 8.6 10.3
SS*2 emissions t 2.7 2.2 1.4

*1 BOD (biological oxygen demand): Value representing the amount of oxygen consumed when organics are decomposed by microorganisms in water
*2 SS (suspended solids): Volume of solid particles whose diameter is 2 mm or under that remain in suspension in water

Total waste emissions / Final waste disposal volume / Recycling rate
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Total waste generated t 3,607 3,722 3,358
Amount of resources recycled
(Amount of valuable resources)		 t 530 541 477
Recycling rate
(Valuable resource rate)		 % 14.7 14.5 14.2
Final waste disposal volume t 8 8 7
Final waste disposal rate % 0.22 0.21 0.22
Generation intensity
(Total amount of waste generated/Non-consolidated net sales）		 t/million yen 0.04 0.04 0.03

Waste emissions at overseas factories

Overseas subsidiaries Unit FY2021 FY2022 FY2023
Total of overseas subsidiaries Total waste generated t 1,282 1,844 1,243
Noven Total waste generated t 287 399 156
 Amount of industrial waste t 240 347 86
 Amount recycled t 47 52 70
Hisamitsu Vietnam Total waste generated t 247 363 280
 Amount of industrial waste t 196 323 245
 Amount recycled t 51 40 35
Hisamitsu Indonesia Total waste generated t 97 444 448
 Amount of industrial waste t 97 399 391
 Amount recycled t ー 45 57
Hisamitsu Brazil Total waste generated t 613 638 359
 Amount of industrial waste t 572 593 321
 Amount recycled t 41 45 38

Management of Specified Chemical Substances
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Toluene
(PRTR＊ Substances)		 Handling volume t 3.3 3.7 3.4
Emission into the air t 0.2 0.2 0.2
Waste disposal t 3.1 3.5 3.2
Acetonitrile
(Excluding April 1, 2023)		 Handling volume t 4.3 3.3 3.0
Waste disposal t 4.3 3.3 3.0

*PRTR Act: A law that requires the release amounts of certain chemical substances into the environment to be monitored and reported to the government

Air pollutant emissions
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
SOx (sulfur oxide) emissions t 0.9 0.7 0.5
NOx (nitrogen oxide) emissions t 2.8 1.8 1.7

Acquisition status of ISO 14001 certification

Certification scope (organization name) Certification acquisition date Acquisition rate
Kyushu Head Office December 24, 1999 Acquisition rate at two domestic pharmaceutical manufacturing factories: 100%
Utsunomiya Factory

Acquisition status of ISO 45001 certification

Certification scope (organization name) Certification acquisition date Acquisition rate
Kyushu Head Office December 25, 2019 Acquisition rate at two domestic pharmaceutical manufacturing factories: 100%
Utsunomiya Factory

Compliance with environmental laws and regulations (Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Number of violations of environmental laws and regulations Case 0 0 0
 Number of violations related to water
 quality and quantity		 Case 0 0 0

Environmental accounting
Environmental Conservation Cost
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])Unit: 1,000 yen

Category FY2021 FY2022 FY2023
Facilities Expenses Total Facilities Expenses Total Facilities Expenses Total
Pollution prevention 1,330 26,992 28,322 0 33,164 33,164 0 46,402 46,402
Global environmental protection 102,929 68,127 171,056 307,300 98,274 405,574 274,390 174,596 448,986
Resource recycling 190,800 150,744 341,544 273,708 155,529 429,237 172,858 166,701 339,559
Upstream/Downstream 0 15,185 15,185 0 16,359 16,359 0 20,119 20,119
Management activities 0 67,912 67,912 0 68,214 68,214 0 68,150 68,150
Social activities 0 7,914 7,914 0 5,914 5,914 0 4,897 4,897
Environmental damage response 0 523 523 0 488 488 0 482 482
Other 0 0 0 0 0 0 0 0 0
Total 295,059 337,397 632,456 581,008 377,942 958,950 447,248 481,347 928,595

Environmental Conservation Effect
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Energy consumption
(crude oil equivalent)		 kL 12,153 11,170 11,517
CO₂ emissions t 22,785 22,140 22,468
SOx emissions t 0.9 0.7 0.5
NOx emissions t 2.8 1.8 1.7
Water withdrawal 1,000㎥ 177 174 173
Drainage volume 1,000㎥ 93 87 87
BOD emissions t 9 9 10
Waste emissions t 3,607 3,722 3,358

Percentage of hybrid vehicles in all corporate sales vehicles
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Percentage of hybrid vehicles % 90.7 93.5 98.8

Employee data (Consolidated)

Unit FY2021 FY2022 FY2023
Consolidated number of employees Person 2,784 2,769 2,759
 Number of domestic employees Person 1,644 1,579 1,568
 Number of overseas employees Person 1,140 1,190 1,191
 Number of male employees* Person ー 1,654 1,640
 Number of female employees* Person ー 1,115 1,119
 Ratio of female employees* % ー 40.3 40.6

* Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated]/Domestic subsidiaries: As of the end of February; Overseas subsidiaries: As of the end of December

Employee data
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated]; As of the end of February each fiscal year)

Unit FY2021 FY2022 FY2023
Number of employees Person 1,587 1,521 1,506
 Number of male employees Person 1,119 1,070 1,042
 Number of female employees Person 468 451 464
 Ratio of female employees % 29.5 29.7 30.8
Ratio of female managers* % 7.1 7.9 7.8
Average age Age 38.0 38.9 39.4
Average length of service Year 14.4 15.3 15.8
Elderly employment rate % 3.18 3.29 4.56
Employment rate of
persons with disabilities		 % 1.99 1.95 2.31
Number of new employees Person 72 10 54
 Number of new male employees Person 45 4 26
 Number of new female employees Person 27 6 28
 Ratio of new female employees % 37.5 60.0 51.9
Mid-career hiring rate % 5 55 16
Voluntary turnover rate % 3.4 3.7 4.0

* As of the end of March each fiscal year

Gender wage difference
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated]; Ratio of women's wages to men's wages)

Unit FY2021 FY2022 FY2023
Regular employees % ー 76.1 74.3
Part-time/fixed-term employees % ー 92.6 90.0
All employees % ー 75.7 74.5

Training
(Hisamitsu Pharmaceutical Co., Inc.
[Non-consolidated]）

Unit FY2021 FY2022 FY2023
Total training time* hours 5,664 3,572 8,958
Training time per employee* hours/person 3.6 2.3 5.9

* Training sessions organized by the Human Resources Division

Data related to work-life management
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Number of days of paid leave taken Day 11.1 13.3 13.4
Rate of paid leave taken % 60.6 72.1 71.7
Number of employees taking maternity leave Person 30 31 24
Number of employees taking childcare leave Person 39 66 48
 Male Person 17 29 24
 Female Person 22 37 24
Rate of employees taking childcare leave % 40 72 61
 Rate of male employees taking childcare  leave % 24 50 42
 Rate of female employees taking
 childcare leave		 % 84 108 109
Rate of return to work after childcare leave % 98.0 98.4 100.0

Data related to occupational safety and health
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Number of workplace accidents Case 7 8 8
Number of workplace accidents requiring absence from work Case 2 3 0
Workplace accident frequency rate* % 0.55 0.85 0.00

*Number of casualties due to workplace accidents / Total work hours x 1,000,000

Data related to group support activities
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Support activities for NPOs and civic organizations by Hisamitsu-Hot-Heart Club

Unit FY2021 FY2022 FY2023
Number of groups supported Group 44 39 41
Donation amount 1,000 yen 4,400 3,900 4,100

Data related to disaster relief activities and fundraising activities
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2021 FY2022 FY2023
Donation*1 Yen 2,257,509 16,595,993 1,435,394
Provision of supplies*2 Pieces / Bottles (1)5,040sheets ー (1)28,800sheets
(2)250boxes
(3)70pieces
International charity drive*3 Yen 231,236 601,975 601,975

*1: Including donations from Hisamitsu-Hot-Heart Club and from employees
*2: Provision of supplies based on the Agreement of Support and Cooperation at the Time of a Disaster signed by the Japanese Red Cross Society in January 2020
(1)HisamitsuⓇ Refresh Body Sheet, (2)Heating device JikabariⓇ, (3)FeitasⓇ ACTIVE SUPPORTER
*3: In FY2020 and FY2021, charity drives were held with donation boxes set up in order to help prevent the spread of COVID-19.

Directors / Corporate Auditors
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated]; As of the end of February each fiscal year)

Unit FY2021 FY2022 FY2023
Directors Person 10 9 9
 Outside Directors Person 4 3 3
 Female Directors Person 0 0 1
 Ratio of Outside Directors % 40.0 33.3 33.3
Corporate Auditors Person 4 4 4
 Outside Corporate Auditors Person 2 2 2
 Ratio of Outside Corporate Auditors % 50.0 50.0 50.0
Number of meetings of the Board of Directors Time 9 7 7
Board of Directors meeting attendance rate (all Directors) % 100.0 97.0 100.0
Board of Directors meeting attendance rate (all Auditors) % 97.2 100.0 96.4
Number of meetings of the Board of Corporate Auditors Time 6 7 8
Number of meetings of the Nomination and Remuneration Committee Time 1 1 1

Corruption prevention

Unit FY2021 FY2022 FY2023
Fines, penalties, and settlement costs related to bribery and anti-corruption violations 1,000 yen 0 0 0
Number of disciplinary dismissal cases due to bribery and anti-corruption violations Case 0 0 0
Amount of direct political contributions 1,000 yen 0 0 0

PAGETOP